Market Cap of Starpharma

One day before release of cap raising Starpharma was worth 615 million dollars (373 million shares@$1.605)
Today it's market capitalisation is 517 million dollars (406 million [email protected])
A drop of 98 million dollars
All things considered equal with dilution the share price should be @$1.51
This is a 20% drop
Every single biotech company is going up in this bull market
TLX has RAC continued to power ahead today and yet SPL continues to languish



We have over $70 million in the bank
We are the world leader in dendrimer development
We have multiple undisclosed collaborations with major pharmaceutical companies
We have multiple drugs in preclinical development
We have four drugs in phase 2 human trials completing within six months
We have a broad spectrum antiviral which will be in the market sometime in the next six months
We have a non antibiotic solution for BV licensed in 161 countries


WHAT WE DON'T HAVE IS A MARKETING AND PR COMPANY THAT PROMOTES STARPHARMA IN THE WAY IT SHOULD

Here is the catch phrase of our PR firm (WE COMMUNICATIONS - previously known as Buchan Consulting)



WE is one of the largest communications and integrated marketing agencies in the world. We’re independent, we’re all about our people — both our clients and our employees — and we believe in the power of communications to move audiences to positive action.

We create conversation-starting work for our clients in the technology, health and consumer sectors. Our campaigns boost adoption, build reputation, drive real business results — even inspire bedrock change. Welcome to WE. Let’s build some momentum together.